Nakamoto, Inc. (NAKA)
5.00
-0.79
(-13.64%)
USD |
NASDAQ |
Nov 13, 16:00
4.93
-0.07
(-1.40%)
After-Hours: 19:59
Nakamoto Shareholders Equity (Quarterly) : 324.28M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 324.28M |
| June 30, 2026 | 236.41M |
| March 31, 2026 | 367.07M |
| December 31, 2025 | 514.26M |
| September 30, 2025 | 477.56M |
| June 30, 2025 | 8.967M |
| March 31, 2025 | 1.529M |
| December 31, 2024 | 2.568M |
| Date | Value |
|---|---|
| September 30, 2024 | 3.484M |
| June 30, 2024 | 4.381M |
| March 31, 2024 | -0.3831M |
| December 31, 2023 | -0.1084M |
| September 30, 2023 | -0.1924M |
| June 30, 2023 | -0.0584M |
| March 31, 2023 | 0.3013M |
| December 31, 2022 | 0.381M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Astrana Health, Inc. | 856.62M |
| Agilon Health, Inc. | 280.88M |
| Starling Oncology, Inc. | -37.36M |
| American Oncology Network, Inc. | -- |
| Biodesix, Inc. | 8.675M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 517.19M |
| Total Liabilities (Quarterly) | 192.92M |
| Debt to Equity Ratio | 0.5084 |
| Current Ratio | 0.2278 |
| Net Debt Paydown Yield | -18.93% |